Print this page    •   Back to Web version of article

Calypte HIV Test Gets OK in Kenya

March 30, 2006

On Tuesday, Calypte Biomedical Corp. said its oral and blood rapid-result HIV tests have been approved for sale in Kenya. Kenya, a nation of more than 30 million, including 1.2 million HIV-positive people, now has more than 350 registered sites where residents can receive HIV testing and counseling. The approval means Calypte can compete for Kenyan government contracts, anticipated to be announced later this year, for more than 4 million tests. The company said the United States is expected to provide more than $200 million in HIV/AIDS funding this year for Kenya, which is one of the 15 nations targeted by President Bush's Emergency Plan for AIDS Relief.

Back to other news for March 30, 2006

Excerpted from:
Associated Press

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.